VYOME HOLDINGS, INC. Income Taxes Paid
VYOME HOLDINGS, INC. (HIND) reported Income Taxes Paid of $4.65 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-12
- VYOME HOLDINGS, INC. income taxes paid, net for the quarter ending 2026-06-30 was $1.80K.
- VYOME HOLDINGS, INC. income taxes paid, net for the quarter ending 2026-03-31 was $2.85K, a 29.14% decline year-over-year.
- VYOME HOLDINGS, INC. income taxes paid, net for the quarter ending 2025-06-30 was -$1.40K, a 134.95% decline year-over-year.
- VYOME HOLDINGS, INC. income taxes paid, net for the quarter ending 2025-03-31 was $4.01K, a 49.81% decline year-over-year.
- VYOME HOLDINGS, INC. income taxes paid, net for fiscal 2024 was $12.00K, a 20.00% increase from fiscal 2023.
- VYOME HOLDINGS, INC. income taxes paid, net for fiscal 2023 was $10.00K, a 100.00% increase from fiscal 2022.
- VYOME HOLDINGS, INC. income taxes paid, net for fiscal 2022 was $5.00K, a 95.10% decline from fiscal 2021.
- VYOME HOLDINGS, INC. income taxes paid, net for fiscal 2021 was $102.00K, a 155.00% increase from fiscal 2020.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 3 month as first filed | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 6 month as first filed | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.65K 10-Q · filed 2026-08-12 | ||||
| 2026-03-31 | $2.85K 10-Q · filed 2026-05-12 | |||||
| 2025-06-30 | -$1.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.62K 10-Q · filed 2026-08-12 | $154.00K 10-Q · filed 2025-08-14 | $2.62K derived: sum of 3 quarters · filed 2026-08-12 | $2.62K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $4.01K 10-Q · filed 2026-05-12 | $154.00K 10-Q · filed 2025-05-20 | $4.01K derived: sum of 2 quarters · filed 2026-05-12 | $4.01K derived: sum of 3 quarters · filed 2026-05-12 | $8.02K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $0.00 derived: sum of 2 quarters · filed 2025-04-04 | $4.00K derived: sum of 3 quarters · filed 2025-08-14 | $12.00K 10-K · filed 2025-04-04 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.00K derived: sum of 2 quarters · filed 2025-08-14 | $12.00K 10-Q · filed 2024-11-14 | $20.00K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $12.00K 10-Q · filed 2025-08-14 | $20.00K derived: sum of 3 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-20 | $16.00K derived: sum of 2 quarters · filed 2025-05-20 | ||||
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $10.00K 10-K · filed 2025-04-04 | ||||
| 2023-09-30 | $2.00K 10-Q · filed 2024-11-14 | |||||
| 2022-12-31 | $5.00K 10-K · filed 2024-04-01 | |||||
| 2021-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $71.00K derived: sum of 2 quarters · filed 2023-04-17 | $71.00K derived: sum of 3 quarters · filed 2023-04-17 | $102.00K 10-K · filed 2023-04-17 | ||
| 2021-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $6.00K derived: sum of 2 quarters · filed 2022-11-14 | $37.00K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $31.00K 10-Q · filed 2022-08-19 | ||||
| 2021-03-31 | $31.00K 10-Q · filed 2022-05-23 | |||||
| 2020-12-31 | $40.00K 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |